Global Cannabis
Khiron Enters the UK with Project Twenty21
On May 6th, 2020 Khiron announced the Company received its first medical
cannabis prescription in the UK. Khiron is the exclusive Latin American Company
participating in the project.
66.4 M
population
United Kingdom
US$ 1.3 Billion
TAM
Medical cannabis 2024 ¹
●
....
*
....
Europe's 1st & largest national medical cannabis registry
(Chronic pain, epilepsy, PTSD, MS, Substance Abuse,
Anxiety)
400,000
Medical cannabis patients
by 2024¹
Treatments provided at clinics in the UK. or through
doctor prescription
Create evidence for the effectiveness and tolerability of
medical cannabis in UK
Drug
Science
Goal to reach 20,000 patients by end of 2021
Dy RE
1- Prohibition Partners - The UK Cannabis Report, January 2020
RC
PSYCH
ROYAL COLLEGE OF
PSYCHIATRISTS
7.3 Million
People use CBD in the UK
every year¹
14
THE BRITISH
PAIN SOCIETY
EXPERTISE WHERE IT MATTERS
KHIRON
LIFE SCIENCES CORP
PLEA
For Quality of Life with
Medical CannabisView entire presentation